Summary
169.18 3.78(2.29%)07/26/2024
Allstate Corp (The) (ALL)
Allstate Corp (The) (ALL)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 2.31 | -2.98 | 6.77 | -0.52 | 6.83 | 51.03 | 82.96 | 2,239.97 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 169.18 | |
| Open | 166.46 | |
| High | 171.18 | |
| Low | 166.46 | |
| Volume | 1,499,471 | |
| Change | 3.82 | |
| Change % | 2.31 | |
| Avg Volume (20 Days) | 1,163,689 | |
| Volume/Avg Volume (20 Days) Ratio | 1.29 | |
| 52 Week Range | 104.29 - 179.93 | |
| Price vs 52 Week High | -5.97% | |
| Price vs 52 Week Low | 62.22% | |
| Range | 1.63 | |
| Gap Up/Down | -9.76 | |
Fundamentals | ||
| Market Capitalization (Mln) | 44,647 | |
| EBIDTA | 2,723,000,064 | |
| PE Ratio | 37.7096 | |
| PEG Ratio | 3.3970 | |
| WallStreet Target Price | 188.56 | |
| Book Value | 63.0520 | |
| Earnings Per Share | 4.5800 | |
| EPS Estimate Current Quarter | 3.9400 | |
| EPS Estimate Next Quarter | 1.8400 | |
| EPS Estimate Current Year | 14.9200 | |
| EPS Estimate Next Year | 17.5900 | |
| Diluted EPS (TTM) | 4.5800 | |
| Revenues | ||
| Profit Marging | 0.0231 | |
| Operating Marging (TTM) | 0.1030 | |
| Return on asset (TTM) | 0.0126 | |
| Return on equity (TTM) | 0.0729 | |
| Revenue TTM | 58,567,000,064 | |
| Revenue per share TTM | 223.1120 | |
| Quarterly Revenue Growth (YOY) | 0.1070 | |
| Quarterly Earnings Growth (YOY) | -0.6760 | |
| Gross Profit (TTM) | 6,443,000,000 | |
| Dividends | ||
| Dividend Share | 3.5900 | |
| Dividend Yield | 0.0213 | |
| Valuations | ||
| Trailing PE | 37.7096 | |
| Forward PE | 12.8535 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.7901 | |
| Revenue Enterprise Value | 0.9321 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 263,915,008 | |
| Shares Float | 261,970,276 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 0.57 | |
| Institutions (%) | 77.62 | |
07/26 13:49 EST - investorplace.com
Hot Stocks: Top 3 Analyst Upgrades You Can't Ignore in July
Today, we will discuss three recent analyst upgrades on Wall Street. Earnings season is in full swing, and the market is navigating volatility and uncertainty.
Hot Stocks: Top 3 Analyst Upgrades You Can't Ignore in July
Today, we will discuss three recent analyst upgrades on Wall Street. Earnings season is in full swing, and the market is navigating volatility and uncertainty.
07/26 12:45 EST - zacks.com
Why Allstate (ALL) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes?
Why Allstate (ALL) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes?
07/26 10:20 EST - zacks.com
Ahead of Allstate (ALL) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Allstate (ALL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Ahead of Allstate (ALL) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Allstate (ALL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
07/25 16:30 EST - globenewswire.com
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis' UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug (ODD) and Rare Pediatric Disease Designation (RPDD) Status to UCART22 product candidate for the treatment of Acute Lymphoblastic Leukemia (ALL).
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis' UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug (ODD) and Rare Pediatric Disease Designation (RPDD) Status to UCART22 product candidate for the treatment of Acute Lymphoblastic Leukemia (ALL).
07/24 11:06 EST - zacks.com
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/24 09:51 EST - zacks.com
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
07/23 13:11 EST - zacks.com
Will Allstate (ALL) Beat Estimates Again in Its Next Earnings Report?
Allstate (ALL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Allstate (ALL) Beat Estimates Again in Its Next Earnings Report?
Allstate (ALL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
07/22 18:55 EST - zacks.com
Here's Why Allstate (ALL) Gained But Lagged the Market Today
Allstate (ALL) concluded the recent trading session at $174.83, signifying a +0.26% move from its prior day's close.
Here's Why Allstate (ALL) Gained But Lagged the Market Today
Allstate (ALL) concluded the recent trading session at $174.83, signifying a +0.26% move from its prior day's close.
07/17 13:10 EST - businesswire.com
Allstate, Wuerffel Foundation unify college football's highest community service honors
NORTHBROOK, Ill.--(BUSINESS WIRE)--Allstate is partnering with the Wuerffel Foundation to bring together two of the most meaningful awards in college football. The Allstate Wuerffel Trophy will honor a student-athlete who is inspired to serve others and make a positive impact on society. Together with the Allstate AFCA Good Works Team, whose 2024 nominees are announced below, the awards will mark college football's premier honors for community service. “Student-athletes deserve recognition for.
Allstate, Wuerffel Foundation unify college football's highest community service honors
NORTHBROOK, Ill.--(BUSINESS WIRE)--Allstate is partnering with the Wuerffel Foundation to bring together two of the most meaningful awards in college football. The Allstate Wuerffel Trophy will honor a student-athlete who is inspired to serve others and make a positive impact on society. Together with the Allstate AFCA Good Works Team, whose 2024 nominees are announced below, the awards will mark college football's premier honors for community service. “Student-athletes deserve recognition for.
07/15 18:56 EST - zacks.com
Allstate (ALL) Rises Higher Than Market: Key Facts
Allstate (ALL) closed the most recent trading day at $166.91, moving +1.97% from the previous trading session.
Allstate (ALL) Rises Higher Than Market: Key Facts
Allstate (ALL) closed the most recent trading day at $166.91, moving +1.97% from the previous trading session.
07/12 12:51 EST - youtube.com
Goldman Sachs' John Marshall breaks down top earnings trades
John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss tactical trades.
Goldman Sachs' John Marshall breaks down top earnings trades
John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss tactical trades.
07/10 12:51 EST - zacks.com
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes?
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes?
07/08 18:56 EST - zacks.com
Allstate (ALL) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Allstate (ALL) closed at $159.54, indicating a +0.7% shift from the previous trading day.
Allstate (ALL) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Allstate (ALL) closed at $159.54, indicating a +0.7% shift from the previous trading day.
07/05 10:06 EST - zacks.com
Is the Options Market Predicting a Spike in Allstate (ALL) Stock?
Investors need to pay close attention to Allstate (ALL) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Allstate (ALL) Stock?
Investors need to pay close attention to Allstate (ALL) stock based on the movements in the options market lately.
07/05 07:52 EST - investorplace.com
3 Rock-Solid Stocks for Worry-Free Retirement Investing
Investing for retirement, especially choosing what stocks to invest in for the long term, can be daunting. This may cause some investors to procrastinate, creating and building a retirement portfolio based on the unknown regarding overall profitability and whether they made the right choice in stocks to invest.
3 Rock-Solid Stocks for Worry-Free Retirement Investing
Investing for retirement, especially choosing what stocks to invest in for the long term, can be daunting. This may cause some investors to procrastinate, creating and building a retirement portfolio based on the unknown regarding overall profitability and whether they made the right choice in stocks to invest.
07/02 05:10 EST - zacks.com
Allstate (ALL) Rises 45% in a Year: Evaluating the Road Ahead
Allstate (ALL) remains well-poised for growth on higher P&C insurance premiums, strategic acquisitions and cost-cutting initiatives.
Allstate (ALL) Rises 45% in a Year: Evaluating the Road Ahead
Allstate (ALL) remains well-poised for growth on higher P&C insurance premiums, strategic acquisitions and cost-cutting initiatives.
06/26 13:25 EST - businesswire.com
Superscapes Partners with Irving-based On Duty Tree & Landscape Expanding Its Footprint and Portfolio of Services
DALLAS--(BUSINESS WIRE)--Superscapes, an industry leading provider of commercial landscaping services, is pleased to announce the acquisition of On Duty Tree & Landscape (On Duty), marking a strategic move to enhance its presence in North Texas and Houston. Serving the Dallas and Houston markets for the last 16 years, On Duty has garnered a sterling reputation within the commercial landscaping industry. Founded and operated by industry veteran Sha Clayton, the brother of Superscapes CEO Sha.
Superscapes Partners with Irving-based On Duty Tree & Landscape Expanding Its Footprint and Portfolio of Services
DALLAS--(BUSINESS WIRE)--Superscapes, an industry leading provider of commercial landscaping services, is pleased to announce the acquisition of On Duty Tree & Landscape (On Duty), marking a strategic move to enhance its presence in North Texas and Houston. Serving the Dallas and Houston markets for the last 16 years, On Duty has garnered a sterling reputation within the commercial landscaping industry. Founded and operated by industry veteran Sha Clayton, the brother of Superscapes CEO Sha.
06/26 12:51 EST - businesswire.com
Allstate to hold Q2 2024 earnings call Aug. 1
NORTHBROOK, Ill.--(BUSINESS WIRE)--The Allstate Corporation (NYSE: ALL) will host a conference call and webcast at 9 a.m. Eastern on Thursday, Aug. 1, 2024, to discuss second quarter 2024 earnings. The company plans to file a current report on Form 8-K with the Securities and Exchange Commission announcing quarterly results at or after 4:15 p.m. Eastern on Wednesday, July 31. To view Allstate's quarterly results after their filing, including the earnings release and investor supplement, visit t.
Allstate to hold Q2 2024 earnings call Aug. 1
NORTHBROOK, Ill.--(BUSINESS WIRE)--The Allstate Corporation (NYSE: ALL) will host a conference call and webcast at 9 a.m. Eastern on Thursday, Aug. 1, 2024, to discuss second quarter 2024 earnings. The company plans to file a current report on Form 8-K with the Securities and Exchange Commission announcing quarterly results at or after 4:15 p.m. Eastern on Wednesday, July 31. To view Allstate's quarterly results after their filing, including the earnings release and investor supplement, visit t.
06/25 11:05 EST - youtube.com
Allstate CEO on auto insurance prices and inflation
“It'll start coming down,” Allstate CEO Tom Wilson says on inflation in the auto insurance space. NBCUniversal News Group is the media partner of the Aspen Ideas Festival.
Allstate CEO on auto insurance prices and inflation
“It'll start coming down,” Allstate CEO Tom Wilson says on inflation in the auto insurance space. NBCUniversal News Group is the media partner of the Aspen Ideas Festival.
06/25 09:45 EST - youtube.com
Allstate CEO Tom Wilson: Accident reduction from self-driving cars has not yet impacted revenue
Tom Wilson, Allstate CEO, joins CNBC's 'Squawk Box' to discuss inflation, auto and home insurance, and more.
Allstate CEO Tom Wilson: Accident reduction from self-driving cars has not yet impacted revenue
Tom Wilson, Allstate CEO, joins CNBC's 'Squawk Box' to discuss inflation, auto and home insurance, and more.